Related Experiment Video
Updated: Dec 3, 2025

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Efavirenz induces DNA damage response pathway in lung cancer
Rahaba Marima1,2, Rodney Hull1, Zodwa Dlamini1,2
1SA-MRC/UP Precision Prevention and Novel Drug Targets for HIV-Associated Cancers Extramural Unit, Pan African Cancer Research Institute, Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa.
Abstract:
The cell-cycle related genes are potential gene targets in understanding the effects of efavirenz (EFV) in lung cancer. The present study aimed at investigating the expression changes of cell-cycle related genes in response to EFV drug treatment in human non-small cell lung carcinoma (A549) and normal lung fibroblast (MRC-5) cells. The loss in nuclear integrity in response to EFV was detected by 4', 6-diamidino-2-phenylindole (DAPI) staining. Gene expression profiling was performed using human cell cycle PathwayFinder RT2 Profiler™ PCR Array. The expression changes of 84 genes key to the cell cycle pathway in humans following EFV treatment was examined. The R2 PCR Array analysis revealed a change in expression of selected gene targets (including MAD2L2, CASP3, AURKB). This change in gene expression was at least a two-fold between test (EFV treated) and the control. RT-qPCR confirmed the PCR array data. In addition to this, the ATM signaling pathway was shown to be upregulated following EFV treatment in MRC-5 cells. In particular, ATM's upstream activation resulted in p53 upregulation in normal lung fibroblasts. Interestingly, the p53 signaling pathway was activated irrespective of the repressed ATM pathway in A549 cells as revealed by the Ingenuity Pathway Analysis (IPA). These EFV effects are similar to those of ionizing radiation and this suggests that EFV has anti-tumour properties.
Insights
Efavirenz (EFV) alters cell-cycle gene expression in lung cancer cells, impacting pathways like ATM and p53. These findings suggest EFV possesses potential anti-tumour properties.
Area of Science:
- Molecular biology
- Cancer research
- Pharmacology
Background:
- Cell-cycle related genes are crucial for understanding efavirenz (EFV) effects in lung cancer.
- Efavirenz is a drug with potential anti-tumour properties that warrants further investigation in lung cancer models.
Purpose of the Study:
- To investigate the impact of efavirenz (EFV) on cell-cycle gene expression in human non-small cell lung carcinoma (A549) and normal lung fibroblast (MRC-5) cells.
- To identify specific cell-cycle genes and signaling pathways affected by EFV treatment.
Main Methods:
- Utilized 4', 6-diamidino-2-phenylindole (DAPI) staining to assess nuclear integrity changes induced by EFV.
- Performed gene expression profiling using the human cell cycle PathwayFinder RT2 Profiler™ PCR Array to analyze 84 key cell-cycle genes.
- Confirmed gene expression changes using quantitative real-time PCR (RT-qPCR) and Ingenuity Pathway Analysis (IPA).
Main Results:
- EFV treatment caused significant changes (at least two-fold) in the expression of key cell-cycle genes, including MAD2L2, CASP3, and AURKB.
- The ATM signaling pathway was upregulated in normal lung fibroblasts (MRC-5) following EFV treatment, leading to p53 upregulation.
- The p53 signaling pathway was activated in lung cancer cells (A549) independently of the ATM pathway.
Conclusions:
- EFV significantly alters cell-cycle gene expression in lung cancer and normal lung cells.
- EFV's effects on cell-cycle and signaling pathways (ATM, p53) resemble those of ionizing radiation, indicating potential anti-tumour activity.
- EFV demonstrates promise as a therapeutic agent for lung cancer, warranting further investigation.
More Related Videos
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mechanisms of Retrovirus-induced Cancers

